MedPath

Zepol Topical Analgesic

Zepol Topical Analgesic Ointment

Approved
Approval ID

ca20ade6-9b35-40bb-b3b2-fc3a0e1eece9

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Apr 9, 2025

Manufacturers
FDA

Laboratorios Zepol S.A.

DUNS: 853070985

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Camphor, Menthol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55715-001
Application NumberM017
Product Classification
M
Marketing Category
C200263
G
Generic Name
Camphor, Menthol
Product Specifications
Route of AdministrationTOPICAL
Effective DateApril 9, 2025
FDA Product Classification

INGREDIENTS (6)

TURPENTINEInactive
Code: XJ6RUH0O4G
Classification: IACT
EUCALYPTOLInactive
Code: RV6J6604TK
Classification: IACT
PETROLATUMInactive
Code: 4T6H12BN9U
Classification: IACT
THYME OILInactive
Code: 2UK410MY6B
Classification: IACT
CAMPHOR (SYNTHETIC)Active
Quantity: 6.55 g in 100 g
Code: 5TJD82A1ET
Classification: ACTIB
MENTHOLActive
Quantity: 6.55 g in 100 g
Code: L7T10EIP3A
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Zepol Topical Analgesic - FDA Drug Approval Details